In the NBS screening arm of the model, most of the SMA cases (n = 69.44) were detected presymptomatically, with the remaining 3.73 cases detected symptomatically (i.e., the 5% of patients who do not have homozygous deletions in SMN1). Here, SMN1 is linked to proximal spinal muscular atrophy.